Insights Archive
Filter by:
May 30, 2023
New Drug Spotlight: Amjevita
The launch of Amjevita, the first FDA-approved biosimilar for Humira, is big news for pharmacy benefit plan sponsors.
The clear choice in pharmacy benefit management.
Filter by:
May 30, 2023
The launch of Amjevita, the first FDA-approved biosimilar for Humira, is big news for pharmacy benefit plan sponsors.